Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Oct 29, 7:43 PMCovista beats Q1 FY27 estimates, raises FY27 guidance on strong Walden enrollment and Med & Vet margin expansion
Index
RUT
Market Cap
4.26B
Enterprise Value
4.78B
Income
277.80M
Sales
2.00B
Book/sh
42.35
Cash/sh
7.09
Employees
10680
IPO
Jun 21, 1991
P/E
18.68
Forward P/E
12.48
PEG
1.20
P/S
2.13
P/B
2.97
P/C
17.76
P/FCF
12.02
EV/EBITDA
9.87
EV/Sales
2.38
Quick Ratio
0.81
Current Ratio
0.81
Debt/Eq
0.53
LT Debt/Eq
0.50
Option/Short
Yes / Yes
EPS (ttm)
6.74
EPS next Y
10.09
EPS next Q
2.23
EPS this Y
10.21%
EPS next Y
10.94%
EPS next 5Y
10.43%
EPS past 3/5Y
52.14% 38.12%
Sales past 3/5Y
10.44% 16.59%
EPS Y/Y TTM
19.32%
Sales Y/Y TTM
9.28%
EPS Q/Q
11.24%
Sales Q/Q
10.65%
Insider Own
2.89%
Insider Trans
-7.46%
Inst Own
103.00%
Inst Trans
-0.53%
ROA
9.59%
ROE
19.30%
ROIC
13.00%
Gross Margin
60.71%
Oper. Margin
20.07%
Profit Margin
13.87%
SMA20
-2.02%
SMA50
-1.60%
SMA200
5.19%
Trades
Shs Outstand
33.86M
Shs Float
32.88M
52W High
145.43 -13.44%
52W Low
86.97 44.75%
Volatility
2.75% 2.70%
ATR (14)
4.48
RSI (14)
45.75
Beta
0.70
Rel Volume
2.43
Avg Volume
334.92K
Volume
473,578
Perf Week
-4.50%
Perf Month
2.08%
Perf Quarter
-1.26%
Perf Half Y
10.56%
Perf YTD
21.67%
Perf Year
-11.20%
Perf 3Y
145.06%
Perf 5Y
240.88%
Perf 10Y
444.74%
Prev Close
128.76
Price
125.89
Change %
-2.23%
Consensus
Buy
Avg. Price Target
$159.00
Implied Upside
+26.3%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 03, 2026Downgrade
TFC logoTTruist
Buy → Hold$140+11.2%
Mar 24, 2026Initiated
TFC logoTTruist
Buy$130+3.3%
Apr 23, 2025Initiated
JEF logoJJefferies
Buy$135+7.2%
Oct 27, 2023Upgrade
RRobert W. Baird
Neutral → Outperform$47 → $55-56.3%
Jul 07, 2023Upgrade
BMO logoBBMO Capital Markets
Market Perform → Outperform$44-65.0%
Aug 23, 2021Resumed
BMO logoBBMO Capital Markets
Market Perform$40-68.2%
Sep 12, 2019Initiated
SSidoti
Buy
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stephen BeardDirectorOct 09 '26Proposed Sale129.384,667603,816Oct 09 05:15 PM
Beard, Stephen W.Chairman & CEOOct 09 '26Sale130.774,667610,299469,158Oct 09 05:07 PM
Beard, Stephen W.Chairman & CEOOct 08 '26Sale130.373,639474,413473,825Oct 09 05:07 PM
Stephen BeardDirectorOct 08 '26Proposed Sale130.293,639474,125Oct 08 05:47 PM
Gangadharan ManjunathVP, Chief Accounting OfficerAug 27 '26Sale137.181,802247,1985,083Aug 28 04:11 PM
MANJUNATH GANGADHARANOfficerAug 27 '26Proposed Sale137.781,802248,280Aug 27 04:18 PM
Beard, Stephen W.Chairman & CEOAug 11 '26Sale130.343,545462,073415,197Aug 13 04:32 PM
Stephen BeardDirectorAug 11 '26Proposed Sale126.483,545448,372Aug 11 05:00 PM
Phelan Robert J.Chief Financial OfficerAug 07 '26Sale135.152,186295,43848,306Aug 11 04:19 PM
BECK DOUGLAS G.SVP, GC, Corp. Sec & ISSAug 07 '26Sale135.814,526614,67628,544Aug 11 04:18 PM
Beard, Stephen W.Chairman & CEOJul 13 '26Sale132.755,291702,401418,742Jul 15 04:48 PM
Stephen BeardDirectorJul 13 '26Proposed Sale133.185,291704,655Jul 13 04:57 PM
Phelan Robert J.Chief Financial OfficerJul 07 '26Sale135.412,900392,67752,906Jul 09 05:00 PM
Phelan Robert J.Chief Financial OfficerJul 08 '26Sale135.392,414326,82250,492Jul 09 05:00 PM
BECK DOUGLAS G.SVP, GC, Corp. Sec & ISSJul 07 '26Sale135.402,650358,81835,509Jul 09 04:59 PM
BECK DOUGLAS G.SVP, GC, Corp. Sec & ISSJul 08 '26Sale135.342,439330,09233,070Jul 09 04:59 PM
ROBERT PHELANOfficerJul 07 '26Proposed Sale129.567,500971,700Jul 07 04:33 PM
DOUGLAS BECKOfficerJul 07 '26Proposed Sale129.569,6151,245,719Jul 07 04:33 PM
Beard, Stephen W.Chairman & CEOJun 10 '26Sale130.142,762359,443426,562Jun 12 08:01 PM
Beard, Stephen W.Chairman & CEOJun 11 '26Sale130.782,529330,755424,033Jun 12 08:01 PM
Stephen BeardDirectorJun 11 '26Proposed Sale131.892,529333,550Jun 11 06:29 PM
Stephen BeardDirectorJun 10 '26Proposed Sale130.252,762359,750Jun 10 05:58 PM
Phelan Robert J.Chief Financial OfficerMay 08 '26Sale126.2110,0001,262,06455,806May 12 04:56 PM
BECK DOUGLAS G.SVP, GC, Corp. Sec & ISSMay 08 '26Sale127.039,6151,221,38138,159May 12 04:55 PM
Cox Karen SuePresident, Chamberlain Univ.May 08 '26Sale124.502,000249,00031,596May 12 04:53 PM
Beard, Stephen W.Chairman & CEOMay 08 '26Sale131.2515,8742,083,509429,324May 12 04:51 PM
Stephen BeardOfficerMay 08 '26Proposed Sale133.7315,8742,122,830May 08 06:13 PM
ROBERT PHELANOfficerMay 08 '26Proposed Sale117.0010,0001,170,000May 08 04:22 PM
DOUGLAS BECKOfficerMay 08 '26Proposed Sale117.009,6151,124,955May 08 04:22 PM
KAREN COXOfficerMay 08 '26Proposed Sale117.002,000234,000May 08 04:21 PM
MAURICE HERRERAFormer OfficerMay 08 '26Proposed Sale131.6514,7211,937,970May 08 04:10 PM
MALAFRONTE MICHAEL WLead Independent DirectorMar 10 '26Buy100.8615,3051,543,73416,505Mar 12 09:01 AM
MALAFRONTE MICHAEL WLead Independent DirectorMar 10 '26Buy100.8611,8411,194,339113,205Mar 12 09:01 AM
MALAFRONTE MICHAEL WLead Independent DirectorMar 11 '26Buy100.948,890897,34125,395Mar 12 09:01 AM
MALAFRONTE MICHAEL WLead Independent DirectorMar 03 '26Buy97.971,200117,5641,200Mar 05 04:31 PM
Phelan Kenneth JDirectorNov 05 '25Buy98.2950849,93118,783Nov 05 04:12 PM
MALAFRONTE MICHAEL WLead Independent DirectorNov 04 '25Buy91.851,00091,850100,445Nov 04 04:43 PM
Covista, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
CEO & ChairmanMr. Stephen W. Beard J.D.
Senior VP of Institutional Support ServicesMr. Douglas G. Beck J.D.
Chief Growth & Innovation OfficerMr. Michael Betz
Chief Strategy & Performance Officer and President of Medical and VeterinaryMr. Scott Day Liles
VP & Chief Accounting OfficerMr. Manjunath Gangadharan